Bookbuilding IPO | ₹152 Cr | Listed at BSE, NSE | Wed, Sep 27, 2023 - Tue, Oct 3, 2023
Valiant Laboratories IPO is a book build issue of ₹152.46 crores. The issue is entirely a fresh issue of 1.09 crore shares of ₹152.46 crore.
Valiant Laboratories IPO bidding started from Sep 27, 2023 and ended on Oct 3, 2023. The allotment for Valiant Laboratories IPO was finalized on Oct 5, 2023. The shares got listed on BSE, NSE on Oct 6, 2023.
Valiant Laboratories IPO price band is set at ₹140 per share. The lot size for an application is 105. The minimum amount of investment required by an retail is ₹14,700 (105 shares) (based on upper price). The lot size investment for sNII is 14 lots (1,470 shares), amounting to ₹2,05,800, and for bNII, it is 69 lots (7,245 shares), amounting to ₹10,14,300.
Unistone Capital Pvt.Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Valiant Laboratories IPO RHP for detailed Information.
IPO Open
Wed, Sep 27, 2023
IPO Close
Tue, Oct 3, 2023
Issue Price
₹140 per share
Market Cap (Pre-IPO)
₹608.30 Cr
| IPO Date | 27 Sep to 3 Oct, 2023 |
| Listed on | Fri, Oct 6, 2023 |
| Face Value | ₹10 per share |
| Price Band | ₹133 to ₹140 |
| Issue Price | ₹140 per share |
| Lot Size | 105 Shares |
| Sale Type | Fresh capital only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 1,08,90,000 shares (agg. up to ₹152 Cr) |
| Fresh Issue | 1,08,90,000 shares (agg. up to ₹152 Cr) |
| Share Holding Post Issue | 4,34,50,000 shares |
| BSE Script Code / NSE Symbol | 543998 / VALIANTLAB |
| ISIN | INE0JWS01017 |
Valiant Laboratories IPO offers total 1,08,90,000 shares. Out of which 54,45,000 (50.00%) allocated to QIB, 21,78,030 (20.00%) allocated to QIB (Ex- Anchor), 16,33,500 (15.00%) allocated to NII 38,11,500 (35.00%) allocated to RII and 32,66,970 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 54,45,000 (50.00%) | NA |
| − Anchor Investor Shares Offered | 32,66,970 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 21,78,030 (20.00%) | NA |
| NII (HNI) Shares Offered | 16,33,500 (15.00%) | NA |
| − bNII > ₹10L | 10,89,000 (10.00%) | 740 |
| − sNII < ₹10L | 5,44,500 (5.00%) | 370 |
| Retail Shares Offered | 38,11,500 (35.00%) | 36,300 |
| Total Shares Offered | 1,08,90,000 (100.00%) |
Investors can bid for a minimum of 105 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 105 | ₹14,700 |
| Retail (Max) | 13 | 1,365 | ₹1,91,100 |
| S-HNI (Min) | 14 | 1,470 | ₹2,05,800 |
| S-HNI (Max) | 68 | 7,140 | ₹9,99,600 |
| B-HNI (Min) | 69 | 7,245 | ₹10,14,300 |
Valiant Laboratories IPO raises ₹45.74 crore from anchor investors. Valiant Laboratories IPO Anchor bid date is September 26, 2023.
📝 Anchor Investors Letter (PDF)
| Bid Date | Tue, Sep 26, 2023 |
| Shares Offered | 32,66,970 |
| Anchor Portion (₹ Cr.) | 45.74 |
| Anchor lock-in period end date for 50% shares (30 Days) | Sat, Nov 4, 2023 |
| Anchor lock-in period end date for remaining shares (90 Days) | Wed, Jan 3, 2024 |
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
The company's manufacturing unit is located in Palghar, Maharashtra, spread across 2,000 sq. mts. of land with an aggregate annual total installed capacity of 9,000 MT per annum. Valiant Laboratories also has an R&D Facility, equipped with an analytical laboratory and infrastructure for developmental activities in existing products.
For the Fiscal 2023, Fiscal 2022 and Fiscal 2021, Valiant Laboratories revenue from operations was Rs. 3,339.10 million, Rs. 2,915.23 million and Rs. 1,823.69 million, respectively.
Valiant Laboratories Limited imports Para Amino Phenol, being the raw material for the manufacture of Paracetamol from China and Cambodia.
As of April 30, 2023, Valiant Laboratories has 86 employees.
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 212.76 | 181.81 | 106.31 |
| Total Income | 338.77 | 293.47 | 183.78 |
| Profit After Tax | 29.00 | 27.50 | 30.59 |
| NET Worth | 100.49 | 71.46 | 88.58 |
| Total Borrowing | 59.40 | 60.68 | 0.35 |
| Amount in ₹ Crore | |||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in VASPL for partfinancing its capital expenditure requirements in relation to the setting up of the Proposed Facility | 80.00 |
| 2 | Investment in VASPL for funding its working capital requirements; and | 45.00 |
| 3 | General corporate purposes | 9.32 |
| Total | 134.32 |
| KPI | |
|---|---|
| ROE | 33.73% |
| ROCE | 22.76% |
| Debt/Equity | 0.59 |
| RoNW | 28.86% |
| PAT Margin | 8.56% |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 8.91 | |
| P/E (x) | 15.71 | |
| Promoter Holding | 100.00% | 74.94% |
| Market Cap | ₹608.30 Cr. |
The Valiant Laboratories IPO is subscribed 29.76 times on October 3, 2023 7:02:00 PM (Day 4). The public issue subscribed 16.06 times in the retail category, 20.83 times in the QIB category, and 73.64 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 20.83 | 21,78,030 | 4,53,61,155 |
| NII | 73.64 | 16,33,500 | 12,02,88,945 |
| bNII (bids above ₹10L) | 78.64 | 10,88,999 | 8,56,36,635 |
| sNII (bids below ₹10L) | 63.64 | 5,44,501 | 3,46,52,310 |
| Retail | 16.06 | 38,11,500 | 6,11,98,410 |
| Total | 29.76 | 76,23,030 | 22,68,48,510 |
Total Application : 6,76,145
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | BRLM fees and commissions (including any underwriting commission, brokerage and selling commission) | 6.08 |
| 2 | Commission/processing fee for SCSBs, Sponsor Bank(s) and Bankers to the Issue. Brokerage, underwriting commission and selling commission and bidding charges for members of the Syndicate, Registered Brokers, RTAs and CDPs | 1.01 |
| 3 | Fees payable to Registrar to the issue | 0.10 |
| 4 | Others - Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses | 1.49 |
| 5 | - Printing and stationery | 1.00 |
| 6 | - Fee payable to legal counsels | 0.30 |
| 7 | - Advertising and marketing | 7.12 |
| 8 | Miscellaneous | 1.04 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹140.00 | ₹140.00 |
| Open | ₹161.00 | ₹162.15 |
| Low | ₹161.00 | ₹162.10 |
| High | ₹169.05 | ₹170.25 |
| Last Trade | ₹169.05 | ₹170.25 |
Lead Manager Reports
Valiant Laboratories IPO is a main-board IPO of 1,08,90,000 equity shares of the face value of ₹10 aggregating up to ₹152 Crores. The issue is priced at ₹140 per share. The minimum order quantity is 105.
The IPO opens on Wed, Sep 27, 2023, and closes on Tue, Oct 3, 2023.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Valiant Laboratories IPO using UPI as a payment gateway. Zerodha customers can apply in Valiant Laboratories IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Valiant Laboratories IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Valiant Laboratories IPO opens on Wed, Sep 27, 2023 and closes on Tue, Oct 3, 2023.
Valiant Laboratories IPO lot size is 105, and the minimum amount required for application is ₹14,700.
You can apply in Valiant Laboratories IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Valiant Laboratories IPO will be done on Thursday, October 5, 2023, and the allotted shares will be credited to your demat account by Fri, Oct 6, 2023. Check the Valiant Laboratories IPO allotment status.
The Valiant Laboratories IPO listing date is on Fri, Oct 6, 2023.
